Aspira Pathlab & Diagnostics Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

5.93

6.68

10.17

9.37

6.90

Operating profit

-0.70

0.64

3.36

3.00

1.76

Interest

0.19

0.22

0.23

0.14

0.48

Gross profit

-0.65

0.55

3.19

2.91

1.42

EPS (Rs)

-1.39

-0.26

2.25

2.09

0.75

Other income

0.24

0.13

0.06

0.05

0.14

Stock adjustment

-

-

-

-

-

Raw material

1.18

1.23

1.75

1.39

1.31

Power and fuel

-

-

-

-

-

Employee expenses

2.94

2.67

2.66

2.36

1.81

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

2.50

2.14

2.40

2.62

2.01

Provisions made

-

-

-

-

-

Depreciation

0.78

0.82

0.88

0.76

0.72

Taxation

-

-

-

-

-

Net profit / loss

-1.43

-0.27

2.31

2.15

0.70

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.29

10.29

10.29

10.29

9.29

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-11.74

9.52

33.08

32.02

25.59

GPM (%)

-10.46

8.07

31.17

30.87

20.15

NPM (%)

-23.12

-3.97

22.61

22.80

9.94